drugset / Trial / NCT01398046

Effects of Gastric pH on the Pharmacokinetics of Dasatinib

NCT01398046

RandomizedCrossoverOpen-labelBasic science

Summary

The goal of this study is to evaluate the ability of a natural supplement (betaine hydrochloride) to affect the absorption of dasatinib in healthy volunteers. The investigators predict that betaine hydrochloride will increase the absorption of dasatinib, in volunteers pre-treated with proton-pump inhibitors (PPIs).

Timeline

Start
2011-08
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Betaine Small molecule 1500 mg Oral
Subject dasatinib anhydrous Small molecule 100 mg Oral
Background Rabeprazole Small molecule 20 mg Oral

Indications

No indication recorded.